Mark Butler marks reimbursement of BioMarin's achondroplasia therapy

May 25, 2023 Latest News BioPharma

This is a preview of subscriber content

Subscribe now to continue reading.

“I want to particularly congratulate the work of the Murdoch Children’s Research Institute and Professor Ravi Savarirayan who led BioMarin’s development program for VOXZOGO, with the largest clinical trial site in the world," said health minister Mark Butler. …

Subscribe now to continue reading.

Mark Butler marks reimbursement of BioMarin's achondroplasia therapy

This is a preview of subscriber content

Latest Video

Most Read

HTA reform is fine, but why is the underpinning framework immutable?

Olympian joins call urging vigilance on meningococcal risk

Patient Voice Initiative announces the appointment of new president

The need to correct a profound misconception of what ethical decision-making is and is not

New Australian collaboration to build gene and cell therapy production

New Stories

NDIS keeps growing but signs emerge that reforms are starting to work

USTR launches new investigation, with minimal ambition on pharmaceuticals

New Zealand starting to benefit after lifting advertising prohibition

Mark Butler restates support for health technology assessment reform

Brandon BioCatalyst welcomes the inclusion of its CUREator in new program

Cancer Australia launches research program targeting early-onset cancers

Imugene completes significant placement and launches share purchase plan

Sign In

Mark Butler marks reimbursement of BioMarin's achondroplasia therapy

This is a preview of subscriber content

Latest Video

Most Read

HTA reform is fine, but why is the underpinning framework immutable?

Olympian joins call urging vigilance on meningococcal risk

Patient Voice Initiative announces the appointment of new president

The need to correct a profound misconception of what ethical decision-making is and is not

New Australian collaboration to build gene and cell therapy production

Follow Us

New Stories

NDIS keeps growing but signs emerge that reforms are starting to work

USTR launches new investigation, with minimal ambition on pharmaceuticals

New Zealand starting to benefit after lifting advertising prohibition

Mark Butler restates support for health technology assessment reform

Brandon BioCatalyst welcomes the inclusion of its CUREator in new program

Cancer Australia launches research program targeting early-onset cancers

Imugene completes significant placement and launches share purchase plan